item management s discussion and analysis of financial condition and results of operations the following discussion of the financial condition and results of operations of the company should be read in conjunction with selected financial data and the financial statements and the notes thereto included elsewhere in this form k 
overview access worldwide communications  inc  is an outsourced marketing services company that assists clients in the pharmaceutical  telecommunications  financial services and consumer products industries 
the company designs and delivers innovative  data driven sales and marketing solutions that maximize clients sales and profits 
the company has expertise in reaching key pharmaceutical audiences physicians  pharmacists and patients and targeted consumer groups 
access worldwide s resources include proprietary databases of targeted consumers  physicians and pharmacies  strategic planning and market research services  internet services  medical education  medical meetings management  medical publications  inbound and outbound teleservices in different languages  electronic territory management system and drug enforcement agency approved drug sample fulfillment and direct mail capabilities 
revenues the company provides a variety of services for a diverse client base 
the major forms of revenue collection and recognition are as follows 
for medical education and meeting programs  the company generally bills and collects project fees over the life of the project including a percentage of the total project cost at the execution of the work order 
revenues are recognized on the percentage of completion method 

for customized or non standard database projects  the company bills either on a fixed fee or on a per item basis  and revenues are recognized upon delivery of data 
monthly or scheduled data services are billed and revenue is recognized upon delivery of data 

for sample fulfillment services  the company bills and recognizes revenue on a per item basis 

the company leases etms equipment to clients on a per salesperson basis 
revenues are recognized under either an operating or sales type lease 

for teleservices projects  the company bills clients and recognizes revenue on one of the following bases production hours  completed presentations  phone calls placed or received  sales made per hour or a fixed monthly fee 
revenues are recognized as the services are performed on a monthly basis 

for market research projects  the company generally bills and collects fixed project fees in periodic installments over the life of the project including a percentage of the total project costs at the execution of a contract 
revenues are recognized on the percentage of completion method 
cost of revenues cost of revenues consists of expenses specifically associated with client service revenues 
the cost of revenues includes salaries and benefits  commissions paid to sales personnel  purchased services for clients and telephone charges 
selling  general and administrative selling  general and administrative expenses include staff functions such as accounting  information technology and human resources  as well as expenses not directly linked to client service revenues  such as depreciation  amortization and rental expenses 
results of operations by segment for and the following table sets forth  for the periods indicated  certain statements of operations data by segment obtained from the company s statements of operations 
pharmaceutical consumer change change statements of operations data in thousands revenues       cost of revenues       gross profit       selling  general and administrative including unusual charge       amortization expense    operating profit loss       year ended december  compared to year ended december  revenues for the company increased million  or  to million for the year ended december   compared to million for the year ended december  revenues for the pharmaceutical segment increased million  or  to million for the year ended december   compared to million for the year ended december  the increase in revenues for the pharmaceutical segment is primarily the result of twelve months of revenues included in for am medica as compared to three months in the increase in revenues was partly offset by a decrease of million in revenues  which was caused by a non recurring sale of computer equipment for million in which did not occur in the remaining decrease was attributed to a large client opening its own call center and performance issues on certain client contracts which have been resolved 
revenues for the consumer segment increased million  or  to million for the year ended december   compared to million for the year ended december  the increase in the consumer segment is primarily the result of million in new and expanded services revenue which was offset by a decrease of million in revenues from a major client 
the decrease was attributable to an overall reduction in production hours provided by the major client 
cost of revenues for the company increased million  or  to million for  compared to million in cost of revenues as a percentage of revenues for the company increased to for from for cost of revenues as a percentage of revenues for the pharmaceutical segment increased to for compared to for the increase is primarily attributed to tighter labor markets which resulted in higher labor costs 
cost of revenues as a percentage of revenues for the consumer segment increased to for from for the increase was primarily attributed to the expansion of the consumer segment which occurred in the latter part of and into early  in rosslyn  va  plano  tx and boca raton  fl 
during the expansion  the company faced tight labor markets  which resulted in higher personnel turnover  higher recruiting  training and overtime costs 
selling  general and administrative expenses including unusual charge for the company increased million  or  to million for  compared to million for selling  general and administrative expenses including unusual charge as a percentage of revenues increased to for  compared to for selling  general and administrative expenses including unusual charge as a percentage of revenues for the pharmaceutical segment increased to for compared to for excluding am medica  selling  general and administrative expenses including unusual charge as a percentage of revenues increased to for compared to for the increase was primarily attributable to an increase in reserves for bad debts resulting from contract disputes and an increase in headcount to support customer service  sales and information technology 
selling  general and administrative expenses including unusual charge as a percentage of revenues for the consumer segment increased to for  from for the increase was attributed to the expansion of the rosslyn  va  plano  tx  and boca raton  fl facilities which occurred in the latter part of and in early in anticipation of business growth of the consumer segment 
as a result  additional costs were incurred for additional personnel  higher depreciation and leasing costs 
in addition  reserves for bad debts increased due to potential contract disputes relating to the closing realignment of the boca raton operations and consumer segment expansion 
during the second and third quarters of  the company recorded an unusual charge in the amount of million as part of its corporate plan to improve future performance 
the company recorded  which included  and  for the pharmaceutical and consumer segments  respectively in severance costs   in costs incurred due to the company s exploration of strategic alternatives   in deferred acquisition costs incurred on pending acquisitions which were no longer being pursued  and  in costs associated with the ongoing negotiations of the credit facility 
amortization expense for the company increased million  or  to million for  compared to million for the increase was primarily attributable to amortization of goodwill related to the acquisition of am medica and the amortization of goodwill on payments of contingent consideration earned in net interest expense for the company increased million  or  to million for compared to million for the increase was primarily attributed to draws made on the credit facility to acquire am medica in october and to make required payments of contingent consideration earned in in addition  interest expense increased due to the company s default on three loan covenants contained in the credit facility agreement which was subsequently waived see recent developments section 
as a result  the company s interest rate increased from in june to in the fourth quarter of the income tax provision for the company decreased to million in  from million in  primarily as a result of pretax losses in the effective tax rate decreased from in to in results of operations by segment for and the following table sets forth  for the periods indicated  certain statements of operations data by segment obtained from the company s statements of operations 
pharmaceutical consumer change change statements of operations data in thousands revenues       cost of revenues       gross profit       selling  general and administrative       amortization expense  operating profit      year ended december  compared to year ended december  revenues for the company increased million  or  to million for the year ended december   compared to million for the year ended december  revenues for the pharmaceutical segment increased million  or  to million for the year ended december   compared to million  for the year ended december  the increase in revenues for the pharmaceutical segment is primarily the result of twelve months of revenues included in for phoenix marketing group phoenix as compared to two months in  and the acquisition of am medica in october approximately million of the million increase in revenues for the pharmaceutical segment was the result of the acquisitions of phoenix and am medica 
revenues for the consumer segment increased million  or  to million for the year ended december   compared to million for the year ended december  the increase in the consumer segment is primarily the result of continued growth in the business with sprint corp 
cost of revenues for the company increased million  or  to million for  compared to million in cost of revenues as a percentage of revenues for the company decreased to for  from for cost of revenues as a percentage of revenues for the pharmaceutical segment decreased to for compared to for excluding am medica  cost of revenues as a percentage of revenues for the pharmaceutical segment for was as compared to in the decrease was primarily due to reductions in the existing work force at the florida telemarketing facility and the decrease in the ratio of supervisory personnel to total telemarketers 
cost of revenues as a percentage of revenues for the consumer segment declined to for  from for the decrease was the result of better utilization of the company s existing work force because of improved facilities and work practices changes 
selling  general and administrative expenses for the company increased million  or  to million for  compared to million for selling  general and administrative expenses as a percentage of revenues increased to for  when compared to for selling  general and administrative expenses as a percentage of revenues for the pharmaceutical segment decreased slightly to for  compared to for the acquisition of am medica resulted in a decrease of in selling  general and administrative expenses as a percentage of revenues 
the decrease of was partially offset by an increase in the selling  general and administrative expenses as a percentage of revenues due to the acquisition of phoenix  which has a different cost structure than the other businesses  and the expansion of the florida telemarketing facility 
selling  general and administrative expenses as a percentage of revenues for the consumer segment increased to for  from for the increase was primarily the result of an increase in personnel related costs needed to support the growth of this segment 
amortization expense for the company increased million  or  to million for  compared to million for the increase was primarily attributable to amortization of goodwill related to the acquisitions in and the amortization of goodwill on payments of contingent consideration earned in net interest expense for the company decreased million  or  to million for as compared to million for as a result of proceeds used from the offering to reduce borrowings 
the income tax provision for the company increased to million in  from million for  primarily as a result of an increase in pretax earnings 
the effective tax rate decreased from in to in liquidity and capital resources at december   the company had working capital of million  an increase of million from million at december  the company s primary sources of liquidity consist of cash and cash equivalents  and accounts receivable 
as of december   the company had cash and cash equivalents of million  compared to million as of december  net cash used in operating activities during was million  compared to million provided by operating activities during cash used in operating activities consisted of a decrease in accrued interest and other related party expenses of million 
the decrease in accrued interest and other related party expenses is primarily due to contingent payments earned in which were paid during this was offset by a decrease in accounts receivable and unbilled receivables of million 
the company s accounts receivable turnover averaged days for the year ended december   as compared to days for the year ended december  net cash used in investing activities for was million  compared to million in the decrease is primarily attributed to the acquisition of am medica for approximately million in net cash provided by financing activities was million for  compared to million in cash provided by financing activities consisted of draws totaling million as a result of proceeds from the issuance of common stock and draws made on the credit facility to finance payments of contingent consideration earned in and to fund operations 
this was offset primarily by repayments made on related party notes of million and the redemption of  shares of the company s mandatorily redeemable preferred stock  series  at an aggregate price of million 
in addition  during  the proceeds received from the initial public offering were used to retire long term related party debt 
at the end of the second quarter of  the company was in violation of certain financial covenants on its credit facility events of default with the bank group 
as a result  the company began negotiations with the bank group to restructure the credit facility 
on september   the company entered into a forbearance agreement the agreement 
the agreement provided that the bank group a forbear exercising its right to stop making extensions of credit and to accelerate the full outstanding balance on the credit facility  which rights arose from the event of defaults  b agreed not to charge interest on the outstanding balance on the credit facility at the full default rate approximately  and c continued to make available to the company draws as provided under the credit facility 
in addition  the agreement limited the company s ability to draw on its credit facility to million without prior consent of the bank group 
the agreement was amended on october  and expired on november  as of december   the company remained in default on its credit facility and as a result was not allowed to make any payments on its subordinated promissory notes 
therefore  the company failed to meet its scheduled payment of  on its  subordinated promissory note due to the former stockholder of am medica 
the former stockholder s employment agreement contains a provision that in the event of a default on the subordinated promissory note  the company has a period of days to remedy such defaults to keep the employment agreement binding 
the period expires on april  in addition  the company was not permitted to make its january  february  and april payments on its subordinated promissory notes due to the former stockholders of cultural access group  tms and telac  respectively 
on april   the company entered into an amendment agreements and waiver the amendment to the credit facility with the bank group 
the amendment a provides that the bank group waive the events of default and amend certain provisions of the credit facility  including the reestablishment of financial covenants  b limits the revolving credit facility to million  and c increases the interest rate on the outstanding credit facility to prime plus  d allows certain payments to be made by the company on its subordinated promissory notes based on amendment or original agreements amended agreements  e requires payment of a monitoring and amendment fee to the bank group equal to approximately the sum of i the aggregate revolving committed amount and ii the outstanding principal balance of the term loan on such date 
the amendment expires on july  under the amendment and amended agreements  the company is permitted to make monthly payments of  including two payments of  in  to the former stockholder of am medica  to make payments on the remaining balance due on its subordinated promissory notes due to the former stockholders of cultural access group and telac  and to make interest payments only on its subordinated promissory note due to the former stockholder of tms 
the former stockholder of tms has agreed to waive the default on the note 
the company expects to meet its short term liquidity requirements through net cash provided by operations and borrowings under the amendment to the credit facility 
market risk access worldwide is exposed to certain market risks arising from transactions that are entered into in the normal course of business or from acquisitions 
in addition  the company is exposed to market risk from changes in interest rates 
for information regarding the company s debt  see note to the financial statements 
other matters the company experienced no significant computer system failures or disruptions as a result of the changeover from to the year issue  and the year issue had no material adverse affects on the results of operations  liquidity or financial condition of the company 
forward looking statements certain statements under the heading management s discussion and analysis of financial condition and results of operations and elsewhere in this form k constitute forward looking statements within the meaning of the private securities litigation reform act of when used in this report  the words believes  estimates  plans  expects  intends  anticipates  and similar expressions as they relate to the company or its management are intended to identify forward looking statements 
the actual results of the company could differ materially from those indicated by the forward looking statements because of various risks and uncertainties related to and including  without limitation  the company s effective and timely initiation and development of new client relationships and programs  the maintenance of existing client relationships and programs particularly since the company s agreements with its clients generally do not assure the company that it will generate a specific level of revenue  do not designate the company as an exclusive provider and are terminable on short notice  the successful marketing of the company s sales  marketing  internet and medical education services  the achievement of satisfactory levels of both gross and operating margins  the recruitment and retention of qualified personnel  the continued enhancement of telecommunications  computer and information technologies and operational and financial systems  the continued and anticipated growth in industry trends toward outsourcing sales  marketing and medical education services  changes in competition and the forms of direct sales and marketing techniques  customer interest in  and use of  the company s clients products and services  general economic conditions  costs of telephone services  financing and leasing of equipment  the adequacy of cash flows from operations and available financing to fund capital needs and future growth  changes in governmental rules and regulations applicable to the company  and other risks set forth in this report and the company s other filings with the securities and exchange commission 
these risks and uncertainties are beyond the ability of the company to control  and in many cases  the company cannot predict the risks and uncertainties that could cause actual results to differ materially from those indicated by the forward looking statements 
item a 
quantitative and qualitative disclosures about market risk none 

